Other clinical trials of PARP inhibitors in prostate cancer were identified on the ClinicalTrials.gov website, searching for “prostate cancer” and “PARP” for studies published from database inception to July 1, 2019, without language restriction. This evidence concerns the gene PARP1 and prostate carcinoma.